Summary of outcomes and GATA1 mutation types in TAM patients
| Mutation type . | Outcome of TAM . | TAM . | ML-DS . | |||||
|---|---|---|---|---|---|---|---|---|
| CR . | Early death . | Evolved to ML-DS . | NA . | Total (n = 66) . | Total (n = 40) . | |||
| High group | ||||||||
| Loss of 1st Met, n (%) | 7 | 1 | 1 | 1 | 10 (15.2) | 3 (7.5) | ||
| Splicing error, n (%) | 7 | 4 | 0 | 2 | 13 (19.7) | 40 (15.2) | 6 (15.0) | 16 (40.0) |
| PTC 1-3′, n (%) | 10 | 6 | 0 | 1 | 17 (25.8) | 7 (17.5) | ||
| Low group | 26 (39.4) | 24 (60.0) | ||||||
| SPTC 1-5′, n (%) | 6 | 4 | 2 | 3 | 15 (22.7) | 14 (35.0) | ||
| PTC 2, n (%) | 2 | 1 | 8 | 0 | 11 (16.7) | 10 (25.0) | ||
| Mutation type . | Outcome of TAM . | TAM . | ML-DS . | |||||
|---|---|---|---|---|---|---|---|---|
| CR . | Early death . | Evolved to ML-DS . | NA . | Total (n = 66) . | Total (n = 40) . | |||
| High group | ||||||||
| Loss of 1st Met, n (%) | 7 | 1 | 1 | 1 | 10 (15.2) | 3 (7.5) | ||
| Splicing error, n (%) | 7 | 4 | 0 | 2 | 13 (19.7) | 40 (15.2) | 6 (15.0) | 16 (40.0) |
| PTC 1-3′, n (%) | 10 | 6 | 0 | 1 | 17 (25.8) | 7 (17.5) | ||
| Low group | 26 (39.4) | 24 (60.0) | ||||||
| SPTC 1-5′, n (%) | 6 | 4 | 2 | 3 | 15 (22.7) | 14 (35.0) | ||
| PTC 2, n (%) | 2 | 1 | 8 | 0 | 11 (16.7) | 10 (25.0) | ||